Call for Abstracts

Abstract Deadline: February 14, 2027

On June 8–11, 2027, the 69th Annual Thomas L. Petty Aspen Lung Conference will convene at our new venue, The Viceroy in Snowmass Village, Colorado. The conference theme will be “Lung Immunity and Pulmonary Infections.” The 2027 meeting will bring together basic, translational, and clinical investigators to address how acute and chronic lung infections drive pulmonary disease pathobiology, infectious exacerbations of chronic lung disease, and long-term respiratory outcomes—and whether current knowledge is sufficient to advance early diagnostics and personalized therapeutics. The program will emphasize epithelial–immune crosstalk, innate and adaptive mechanisms of host defense, tissue-resident immunity, antibody regulation, the lung microbiome and gut–lung axis, environmental exposures across the lifespan, acute pneumonia and respiratory viral infections, chronic and recurrent lung infections, sepsis biology, and multiomic, imaging, machine-learning, and artificial-intelligence approaches to diagnosis, prognosis, and precision therapy.

The conference will focus on the central question: Is our current understanding of how acute and chronic infections drive the pathobiology, exacerbations, and clinical trajectory of lung disease sufficient for the development of early diagnostics and personalized therapeutics? The program is organized around four integrated themes: (1) epithelial–immune crosstalk and its role in disease onset and infectious exacerbations of COPD, asthma, and idiopathic pulmonary fibrosis; (2) the gut–lung axis, lung microbiome, and environmental exposures as determinants of susceptibility to acute, chronic, and recurrent infection across the lifespan; (3) novel approaches to the diagnosis, phenotyping, and endotyping of acute and chronic lung infections, including molecular diagnostics, image-based analyses, multiomics, and computational approaches for precision therapy; and (4) translational therapeutics for acute pneumonia, ARDS, sepsis, chronic infection, and infection-associated immune dysregulation, with emphasis on neutrophilic inflammation, host–pathogen interactions, and biomarker discovery.

Twelve internationally recognized leaders will present State-of-the-Art lectures, each followed by moderated discussion. Selected abstracts will be presented as brief podium presentations in sessions that follow the invited talks, and additional abstracts will be featured during two evening poster sessions. The meeting will conclude with a Conference Summary by Charles Dela Cruz, M.D., Ph.D., ATSF.

We invite you and your colleagues to submit abstracts related to lung immunity and acute, chronic, and recurrent pulmonary infections, including host–pathogen interactions, infectious exacerbations of chronic lung disease, pneumonia, respiratory viral infection, chronic bacterial and mycobacterial infection, ARDS, sepsis, microbiome biology, environmental susceptibility, biomarker discovery, molecular diagnostics, image-based analysis, multiomics, and precision therapeutics.

Abstracts will be considered for podium and/or poster presentation (abstracts may be similar to those submitted for AAI, ATS, IDWeek, AHA, or other conferences). All abstract submitters are invited to attend the conference, whether or not their abstract is selected, but must register if they plan to attend.

Please use the enclosed Abstract Guidelines as your guide. The deadline for abstract submission is February 14, 2027, and notifications will be sent by March 31, 2027. Seven Travel Awards will be offered to trainees and early-stage investigators with the top-scoring submitted abstracts. Please register if you wish to attend, even if you do not plan to submit an abstract, as we expect a large turnout.

On behalf of the conference co-chairs we look forward to your participation in the 69th Annual Thomas L. Petty Aspen Lung Conference and to a program of outstanding science, collegial exchange, beautiful scenery, and great fun.

Sincerely yours,
Ivor S. Douglas, M.D.
Co-Chair, 69th Annual Meeting
Thomas L. Petty Aspen Lung Conference
Westchester Medical Center
Valhalla, New York, USA

Sarah E. Clark, Ph.D.
Co-Chair, 69th Annual Meeting
Thomas L. Petty Aspen Lung Conference
University of Colorado School of Medicine
Aurora, Colorado, USA

R. Lee Reinhardt, Ph.D.
Co-Chair, 69th Annual Meeting
Thomas L. Petty Aspen Lung Conference
National Jewish Health
Denver, Colorado, USA

To Submit Your Abstract:

1. Adhere to the Abstract Guidelines
2. Complete the Abstract Submission Form​

The deadline for abstract submission is February 14, 2027. Abstracts will be considered for podium and/or poster presentation (abstracts may be similar to those submitted for AAI, ATS, IDWeek, AHA, or other conferences). All abstract submitters are invited to attend the conference, whether or not their abstract is selected, but must register if they plan to attend.

All investigators will be notified on or near March 31, 2027 about acceptance of their abstracts.

Note: We will offer seven Travel Awards to trainees and early-stage investigators with the top-scoring submitted abstracts.

​Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.